The LTB4-BLT1 axis regulates the polarized trafficking of chemoattractant GPCRs during neutrophil chemotaxis

Author:

Subramanian Bhagawat C.1ORCID,Moissoglu Konstadinos1,Parent Carole A.12ORCID

Affiliation:

1. Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA

2. Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA

Abstract

Neutrophils sense and respond to diverse chemotactic cues using G-protein coupled receptors (GPCRs). However, the precise trafficking dynamics of chemoattractant GPCRs during neutrophil activation and chemotaxis remain unclear. Here, using small molecule inhibitors and CRISPR-based knockouts, we establish that two primary chemoattractant GPCRs - formyl peptide receptor 1 (FPR1) and C5a receptor 1 (C5aR) - internalize in a CDC42-Actin-dependent manner. Using live-cell imaging, we demonstrate that upon stimulation FPR1 rapidly clusters, re-distributes along the plasma membrane to the trailing edge, where it internalizes and is directionally trafficked towards the front of migrating primary human neutrophils. In contrast to FPR1 and C5aR, the leukotriene B4 (LTB4) receptor (BLT1), which relays LTB4 signals in response to primary chemoattractants during neutrophil chemotaxis, fails to internalize upon physiological stimulation with LTB4, fMLF or C5a. Importantly, we report that blocking the LTB4-BLT1 axis or downstream Myosin activation enhances the internalization of FPR1 and C5aR, thus reducing downstream signaling and impairing chemotaxis to primary chemoattractants. The polarized trafficking of chemoattractant GPCRs and its regulation by the BLT1-mediated Myosin activation therefore drives persistent chemotactic signaling in neutrophils.

Funder

Intramural Research Program of the Center for Cancer Research, NCI, NIH

Publisher

The Company of Biologists

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3